8-K 1 c82367e8vk.htm FORM 8-K e8vk
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 20, 2004

 
ROCHESTER MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
         
Minnesota   0-18933   41-1613227
 
 
(State or other jurisdiction
of incorporation)		   (Commission file number)   (I.R.S. Employer
Identification No.)
 
One Rochester Medical Drive, Stewartville, MN 55976
(Address of principal executive offices)
     
Registrant’s telephone number, including area code:   (507) 533-9600
   
 
Not Applicable
(Former name or former address, if changed since last report)

 

Item 7. Financial Statements and Exhibits.
Item 12. Results of Operations and Financial Condition.
SIGNATURE
EXHIBIT INDEX
EX-99.1 Press Release

Table of Contents

Item 7. Financial Statements and Exhibits.

     (c)  Exhibits.

     
99.1   Press Release, dated January 20, 2004, issued by Rochester Medical Corporation

Item 12. Results of Operations and Financial Condition.

     On January 20, 2004, Rochester Medical, Inc. issued a press release relating to first quarter financial results for the period ending December 31, 2003. A copy of the press release is attached hereto as Exhibit 99.1.

     The information in this Form 8-K, including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Form 8-K shall not be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

 

Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

January 26, 2004

       
  ROCHESTER MEDICAL CORPORATION
 
  By:   /s/ David A. Jonas
David A. Jonas
Chief Financial Officer

 

Table of Contents

EXHIBIT INDEX

     
Exhibit No.   Description
 
99.1   Press Release, dated January 20, 2004, issued by Rochester Medical Corporation